Quantitative Systematic Strategies LLC Abb Vie Inc. Transaction History

Quantitative Systematic Strategies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $360,270 - $408,961	-3,386 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $1.18 Million - $1.31 Million	-11,211 Reduced 76.8%	3,386 $381,000
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $276,516 - $304,411	2,703 Added 22.73%	14,597 $1.58 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $1.51 Million - $2.04 Million	-18,734 Reduced 61.17%	11,894 $1.27 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $2.37 Million - $2.78 Million	27,611 Added 915.18%	30,628 $2.68 Million
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $221,357 - $296,209	3,017 New	3,017 $296,000
Q1 2020 May 06, 2020	SELL	$64.5 - $97.79 $280,317 - $424,995	-4,346 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $116,489 - $145,753	1,615 Added 59.14%	4,346 $385,000
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $171,998 - $206,791	2,731 New	2,731 $207,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $227,165 - $252,536	-2,555 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $229,387 - $271,417	2,555 New	2,555 $237,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.